Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility
Authors
Keywords
-
Journal
Journal of Diabetes Research
Volume 2018, Issue -, Pages 1-7
Publisher
Hindawi Limited
Online
2018-11-12
DOI
10.1155/2018/1614683
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction
- (2018) Maikel L. Colli et al. EBioMedicine
- Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer
- (2017) Shin Yup Lee et al. GENE
- Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy
- (2017) Andrew Bang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Variant SNPs at the microRNA complementary site in the B7-H1 3′-untranslated region increase the risk of non-small cell lung cancer
- (2017) Wenwen Du et al. Molecular Medicine Reports
- Cellular and Molecular Mechanisms of Diabetic Atherosclerosis: Herbal Medicines as a Potential Therapeutic Approach
- (2017) Jinfan Tian et al. Oxidative Medicine and Cellular Longevity
- Combined immune checkpoint blockade as a therapeutic strategy for BRCA1 -mutated breast cancer
- (2017) Emma Nolan et al. Science Translational Medicine
- Immune signature of metastatic breast cancer: Identifying predictive markers of immunotherapy response
- (2017) Ji-Yeon Kim et al. Oncotarget
- Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients
- (2017) Takashi Nomizo et al. Scientific Reports
- Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression
- (2017) Sebastian Marwitz et al. Clinical Epigenetics
- A polymorphism in the promoter region of PD-L1 serves as a binding-site for SP1 and is associated with PD-L1 overexpression and increased occurrence of gastric cancer
- (2016) Li-Hua Tao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PDCD1 PD-1.3 polymorphism and allergic bronchial asthma in Russian and Buryat patients
- (2016) Elena V. Dmitrieva-Zdorova et al. JOURNAL OF ASTHMA
- Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction
- (2016) Xiao-Lei Shi et al. JOURNAL OF HEPATOLOGY
- Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report
- (2015) Juan Martin-Liberal et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Low programmed cell death-1 (PD-1) expression in peripheral CD4+T cells in Japanese patients with autoimmune type 1 diabetes
- (2015) R. Fujisawa et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Association between PDCD1 Gene Polymorphisms and Risk of Systemic Lupus Erythematosus in Three Main Ethnic Groups of the Malaysian Population
- (2015) Kek Chua et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis
- (2015) Mingyuan Yang et al. JOURNAL OF ORTHOPAEDIC SCIENCE
- The PD-1/PD-Ls pathway and autoimmune diseases
- (2014) Suya Dai et al. CELLULAR IMMUNOLOGY
- PD-L1 gene polymorphisms and low serum level of PD-L1 protein are associated to type 1 diabetes in Chile
- (2014) Carolina Pizarro et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Meta-analysis of genetic polymorphisms in programmed cell death 1
- (2014) Y.H. Lee et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma
- (2013) Weipeng Wang et al. HUMAN GENETICS
- Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
- (2008) Brian T. Fife et al. IMMUNOLOGICAL REVIEWS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started